Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT03226678
What this trial is testing

Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)

Who this might be right for
Warm Autoimmune Hemolytic AnemiaCold Agglutinin Disease
Apellis Pharmaceuticals, Inc. 24
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Not applicableNo Longer AvailableNCT05503550
What this trial is testing

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Not applicableStudy completedNCT06355323
What this trial is testing

Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

Who this might be right for
Primary ImmunodeficiencyCommon Variable ImmunodeficiencyIgg Subclass Deficiency+1 more
CHU de Reims 46
Large-scale testing (Phase 3)Study completedNCT01362140
What this trial is testing

Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
MDS
Amgen 147
Not applicableStudy completedNCT01905774
What this trial is testing

Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox

Who this might be right for
ThalassemiaIron Overload
HaEmek Medical Center, Israel 36
Not applicableUnknownNCT05632874
What this trial is testing

The Effect of Relaxing Breathing Exercise Applied to Patients Before Bone Marrow Biopsy on Vital Signs, Pain and Anxiety Levels

Who this might be right for
Bone Marrow Cancer
Uskudar University 72
Testing effectiveness (Phase 2)Study completedNCT02125318
What this trial is testing

Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Who this might be right for
ThrombocytosisMyeloproliferative Neoplasms
Galena Biopharma, Inc. 18
Not applicableStudy completedNCT05522790
What this trial is testing

Impact of Iron Infusion in Anemic Patients on Their Postoperative Outcome After Colorectal Surgery

Who this might be right for
Anemia, Iron DeficiencyColorectal Surgery
Fondation Hôpital Saint-Joseph 270
Large-scale testing (Phase 3)UnknownNCT03295058
What this trial is testing

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Who this might be right for
Severe Aplastic Anemia
Assiut University 50
Not applicableActive Not RecruitingNCT04378855
What this trial is testing

Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).

Who this might be right for
Myeloproliferative Neoplasm
Gruppo Italiano Malattie EMatologiche dell'Adulto 572
Not applicableUnknownNCT05371743
What this trial is testing

Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Sohag University 2
Testing effectiveness (Phase 2)UnknownNCT03902197
What this trial is testing

CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Xuanwu Hospital, Beijing 50
Large-scale testing (Phase 3)Study completedNCT00910910
What this trial is testing

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Celgene 450
Not applicableEnded earlyNCT03943082
What this trial is testing

Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials

Who this might be right for
Malignant NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of California, San Francisco 252
Not applicableWithdrawnNCT04412135
What this trial is testing

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

Who this might be right for
Hematologic Cancer
University Hospital, Limoges
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Early research (Phase 1)UnknownNCT05007418
What this trial is testing

Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sorrento Therapeutics, Inc. 54
Next Page